Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis
Rapamycin injection ameliorated HLA-B27-mediated gut inflammation and altered the microbiome. Interestingly, microbiome of wild type animals was also altered, suggesting a broader effect of rapamycin on gut microbiome beyond inflammation.